Molecular Human Reproduction, Vol. 5, No. 7, 618-626,
July 1999
© 1999 European Society of Human Reproduction and Embryology
Pentoxifylline-stimulated capacitation and acrosome reaction in hamster spermatozoa: involvement of intracellular signalling molecules
1 Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, and 2 Centre for Cellular and Molecular Biology, Hyderabad, India
We investigated the role of cAMP/cGMP, protein kinases and intracellular calcium ( [Ca2+]i) in pentoxifylline-stimulated hamster sperm capacitation and the acrosome reaction (AR) in vitro. Treatment with pentoxifylline (0.45 mM) initially increased sperm cAMP values 2.8-fold, compared with untreated controls (396 ± 9.2 versus 141 ± 6.0 fmoles/106 spermatozoa; mean ± SEM, n = 6) after 15 min, although by 3 h, cAMP values were similar (503–531 fmoles/106 spermatozoa). cGMP values (~27 fmoles/106 spermatozoa) were the same in treated and control spermatozoa. Both sperm capacitation and the AR, determined from the absence of an acrosomal cap, were stimulated by pentoxifylline; these were almost completely inhibited by a Cl–/ HCO3– antiporter inhibitor (4,4-diisothiocyanato-stilbene-2,2 disulphonic acid; 1 mM) defined from the degree of sperm motility and by a protein kinase A inhibitor (H89; 10 µM). A protein kinase C inhibitor (staurosporine, 1 nM) did not affect pentoxifylline-stimulated capacitation but inhibited the AR by 50%. A protein tyrosine kinase inhibitor (tyrphostin A-47, 0.1 mM) had no effect on either pentoxifylline-stimulated capacitation or AR. A phospholipase A2 inhibitor (aristolochic acid, 0.4 mM) markedly inhibited the pentoxifylline-stimulated AR but not capacitation. When intracellular sperm calcium [Ca2±]i was measured using fura-2-AM, there was an early rise (271 nM at 0.5 h) in pentoxifylline-treated spermatozoa; this appeared to be due to intracellular mobilization rather than to uptake. In the absence of extracellular Ca2+, sperm motility was maintained in the presence of pentoxifylline, but capacitation did not occur; spermatozoa exhibited a low level of hyperactivated motility and had a poor rate of AR (20.5 ± 2.3%). These results suggest that: (i) the pentoxifylline-stimulated early onset of sperm capacitation may be mediated by an early rise in cAMP and [Ca2±]i and involves protein kinase A activity; and (ii) pentoxifylline-stimulated AR may require phospholipase A2 and protein kinase C activity.
calcium/cAMP/hamster/pentoxifylline action/spermatozoa
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. L. Feng, Y. B. Han, A. Hershlag, and L. J. Zheng Impact of Ca2+ Flux Inhibitors on Acrosome Reaction of Hamster Spermatozoa J Androl, July 1, 2007; 28(4): 561 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jimenez-Gonzalez, F. Michelangeli, C.V. Harper, C.L.R. Barratt, and S.J. Publicover Calcium signalling in human spermatozoa: a specialized 'toolkit' of channels, transporters and stores Hum. Reprod. Update, May 1, 2006; 12(3): 253 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Sreekumar, K K Acharya, H S Lalitha, S S Indi, P Bali, and P B Seshagiri Germ cell-specific localization of immunoreactive riboflavin carrier protein in the male golden hamster: appearance during spermatogenesis and role in sperm function Reproduction, May 1, 2005; 129(5): 577 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Alvarez Nurture vs Nature: How Can We Optimize Sperm Quality? J Androl, September 1, 2003; 24(5): 640 - 648. [Full Text] [PDF]
|
|
|
|
|
|
J. Glogowski, D. R. Danforth, and A. Ciereszko Inhibition of Alkaline Phosphatase Activity of Boar Semen by Pentoxifylline, Caffeine, and Theophylline J Androl, November 1, 2002; 23(6): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. V. Holt and R. A. P. Harrison Bicarbonate Stimulation of Boar Sperm Motility via a Protein Kinase A--Dependent Pathway: Between-Cell and Between-Ejaculate Differences Are Not Due to Deficiencies in Protein Kinase A Activation J Androl, July 1, 2002; 23(4): 557 - 565. [Abstract] [Full Text] [PDF]
|
|